Bone turnover markers and sex hormones in men with idiopathic osteoporosis

Background In contrast to osteoporosis in postmenopausal women, osteoporosis in men has received much less attention.

[1]  P. Roberson,et al.  Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. , 1999, The Journal of clinical investigation.

[2]  R. Weinstein,et al.  New Developments in the Pathogenesis and Treatment of Steroid‐Induced Osteoporosis , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  R. Ziegler,et al.  Novel Serum Markers of Bone Resorption: Clinical Assessment and Comparison with Established Urinary Indices , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  S. Ljunghall,et al.  Decreased Estradiol Levels and Free Androgen Index and Elevated Sex Hormone-Binding Globulin Levels in Male Idiopathic Osteoporosis , 1999, Calcified Tissue International.

[5]  S. Chanprasertyothin,et al.  Serum oestradiol and oestrogen‐receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males , 1998, Clinical endocrinology.

[6]  R. Cancedda,et al.  Vis‐à‐Vis Cells and the Priming of Bone Formation , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  C. Christiansen,et al.  Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides. , 1998, Clinical chemistry.

[8]  G G Klee,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Relationship of Serum Sex Steroid Levels and Bone Turnover Markers with Bone Mineral Density in Men and Women: A Key Role for Bioavailable Estroge , 2022 .

[9]  P. Pietschmann,et al.  Interaction of triiodothyronine with 1alpha,25-dihydroxyvitamin D3 on interleukin-6-dependent osteoclast-like cell formation in mouse bone marrow cell cultures. , 1998, Bone.

[10]  D. Eyre.  Bone biomarkers as tools in osteoporosis management. , 1997, Spine.

[11]  E. Barrett-Connor,et al.  Endogenous Sex Steroids and Bone Mineral Density in Older Women and Men: The Rancho Bernardo Study , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  C. Slemenda,et al.  Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens. , 1997, The Journal of clinical investigation.

[13]  R. Francis,et al.  Effect of intermittent cyclical disodium etidronate therapy on bone mineral density in men with vertebral fractures. , 1997, Age and ageing.

[14]  R. Francis,et al.  Androgen Supplementation in Eugonadal Men with Osteoporosis: Effects of Six Months' Treatment on Markers of Bone Formation and Resorption , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  A. Silman,et al.  The prevalence of vertebral deformity in European men and women: The european vertebral osteoporosis study , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  P. Delmas,et al.  Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. , 1994, The Journal of clinical endocrinology and metabolism.

[17]  K. Korach,et al.  Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. , 1994, The New England journal of medicine.

[18]  P. Delmas,et al.  Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. , 1994, The Journal of clinical endocrinology and metabolism.

[19]  K. Khaw,et al.  Sex hormones and bone mineral density in elderly men. , 1993, Bone and mineral.

[20]  D. Eyre,et al.  A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross‐linked N‐telopeptides in urine , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  E. Orwoll,et al.  Vertebral deformity in men , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[22]  P. Pietschmann,et al.  Bone mass and biochemical parameters of bone metabolism in men with spinal osteoporosis , 1992, European journal of clinical investigation.

[23]  C. Christiansen,et al.  Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  D. Baylink,et al.  Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. , 1989, The Journal of clinical endocrinology and metabolism.

[25]  C. Dunstan,et al.  Bone histology in young adult osteoporosis. , 1989, Journal of clinical pathology.

[26]  R. Francis,et al.  Spinal osteoporosis in men. , 1989, Bone and mineral.

[27]  M. Kleerekoper,et al.  Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis. , 1987, The Journal of clinical endocrinology and metabolism.

[28]  R. Francis,et al.  Bone Formation and Resorption as the Determinants of Trabecular Bone Volume in Normal and Osteoporotic Men , 1984, Scottish medical journal.

[29]  L. Melton,et al.  Risk factors for spinal osteoporosis in men. , 1983, The American journal of medicine.

[30]  M. de Vernejoul,et al.  Evidence for defective osteoblastic function. A role for alcohol and tobacco consumption in osteoporosis in middle-aged men. , 1983, Clinical orthopaedics and related research.

[31]  S. Teitelbaum,et al.  Osteoporosis in young men: a syndrome of hypercalciuria and accelerated bone turnover. , 1982, Archives of internal medicine.

[32]  T. Miki,et al.  Risk factors for osteoporosis in men , 2003, Journal of Bone and Mineral Metabolism.

[33]  P. Robey.  Bone Matrix Proteoglycans and Glycoproteins , 2002 .

[34]  J. Risteli,et al.  Assays of type I procollagen domains and collagen fragments: problems to be solved and future trends. , 1997, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[35]  E. Seeman.  Advances in the study of osteoporosis in men , 1996 .

[36]  W. Crowley,et al.  Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. , 1987, Annals of internal medicine.